{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:51:40Z","timestamp":1770295900996,"version":"3.49.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00381-020-04706-3","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T07:02:43Z","timestamp":1596524563000},"page":"2363-2375","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Visual function tests including the role of optical coherence tomography in neurofibromatosis 1"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7799-9022","authenticated-orcid":false,"given":"Daphna","family":"Mezad-Koursh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Bachar Zipori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinah","family":"Zur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lior","family":"Degabli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meital","family":"Ben-Dov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ainat","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,4]]},"reference":[{"key":"4706_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/02688690310001601216","volume":"17","author":"J Astrup","year":"2003","unstructured":"Astrup J (2003) Natural history and clinical management of optic pathway glioma. Br J Neurosurg 17:327\u2013335. https:\/\/doi.org\/10.1080\/02688690310001601216","journal-title":"Br J Neurosurg"},{"key":"4706_CR2","doi-asserted-by":"publisher","unstructured":"Avery RA, Cnaan A, Schuman JS, Trimboli-Heidler C, Chen CL, Packer RJ, Ishikawa H (2015) Longitudinal change of circumpapillary retinal nerve fiber layer thickness in children with optic pathway gliomas. Am J Ophthalmol. https:\/\/doi.org\/10.1016\/j.ajo.2015.07.036","DOI":"10.1016\/j.ajo.2015.07.036"},{"key":"4706_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/WNO.0b013e31822aef82","volume":"31","author":"RA Avery","year":"2011","unstructured":"Avery RA, Fisher MJ, Liu GT (2011) Optic pathway gliomas. J Neuro-Ophthalmology 31:269\u2013278. https:\/\/doi.org\/10.1097\/WNO.0b013e31822aef82","journal-title":"J Neuro-Ophthalmology"},{"key":"4706_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jamaophthalmol.2013.7649","volume":"132","author":"RA Avery","year":"2014","unstructured":"Avery RA, Hwang EI, Ishikawa H, Acosta MT, Hutcheson KA, Santos D, Zand DJ, Kilburn LB, Rosenbaum KN, Rood BR, Schuman JS, Packer RJ (2014) Handheld optical coherence tomography during sedation in young children with optic pathway gliomas. JAMA Ophthalmol 132:265\u2013271. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.7649","journal-title":"JAMA Ophthalmol"},{"key":"4706_CR5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ajo.2010.08.046","volume":"151","author":"RA Avery","year":"2011","unstructured":"Avery RA, Liu GT, Fisher MJ, Quinn GE, Belasco JB, Phillips PC, Maguire MG, Balcer LJ (2011) Retinal nerve fiber layer thickness in children with optic pathway gliomass. Am J Ophthalmol 151:542\u2013549.e2. https:\/\/doi.org\/10.1016\/j.ajo.2010.08.046","journal-title":"Am J Ophthalmol"},{"key":"4706_CR6","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1212\/WNL.0000000000003402","volume":"87","author":"RA Avery","year":"2016","unstructured":"Avery RA, Mansoor A, Idrees R, Trimboli-Heidler C, Ishikawa H, Packer RJ, Linguraru MG (2016) Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1. Neurology 87:2403\u20132407. https:\/\/doi.org\/10.1212\/WNL.0000000000003402","journal-title":"Neurology"},{"key":"4706_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijrobp.2011.10.067","volume":"84","author":"RM Awdeh","year":"2012","unstructured":"Awdeh RM, Kiehna EN, Drewry RD, Kerr NC, Haik BG, Wu S, Xiong X, Merchant TE (2012) Visual outcomes in pediatric optic pathway glioma after conformal radiation therapy. Radiat Oncol Biol 84:46\u201351. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.10.067","journal-title":"Radiat Oncol Biol"},{"key":"4706_CR8","doi-asserted-by":"publisher","unstructured":"Balcer LJ, Liu GT, Heller G, Bilaniuk L, Volpe NJ, Galetta SL, Molloy PT, Phillips PC, Janss AJ, Vaughn S, Maguire MG (2001) Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Am J Ophthalmol. https:\/\/doi.org\/10.1016\/S0002-9394(00)00852-7","DOI":"10.1016\/S0002-9394(00)00852-7"},{"key":"4706_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.spen.2017.04.006","volume":"24","author":"SJ Beres","year":"2017","unstructured":"Beres SJ, Avery RA (2017) Optic pathway gliomas secondary to neurofibromatosis type 1. Semin Pediatr Neurol 24:92\u201399. https:\/\/doi.org\/10.1016\/j.spen.2017.04.006","journal-title":"Semin Pediatr Neurol"},{"key":"4706_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1475-1313.1993.tb00489.x","volume":"13","author":"J Birch","year":"1993","unstructured":"Birch J, Platts C (1993) Colour vision screening in children: an evaluation of three pseudoisochromatic tests. Ophthalmic Physiol Opt 13:344\u2013349","journal-title":"Ophthalmic Physiol Opt"},{"key":"4706_CR11","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1097\/WNO.0000000000000550","volume":"37","author":"PMK de Blank","year":"2017","unstructured":"de Blank PMK, Fisher MJ, Liu GT, Gutmann DH, Listernick R, Ferner RE, Avery RA (2017) Optic pathway gliomas in neurofibromatosis type 1: an update: surveillance, treatment indications, and biomarkers of vision. J Neuroophthalmol 37:S23\u2013S32. https:\/\/doi.org\/10.1097\/WNO.0000000000000550","journal-title":"J Neuroophthalmol"},{"key":"4706_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/ajmg.a.20650","volume":"127A","author":"MA Blazo","year":"2004","unstructured":"Blazo MA, Lewis RA, Chintagumpala MM, Frazier M, McCluggage C, Plon SE (2004) Outcomes of systematic screening for optic pathway tumors in children with neurofibromatosis type 1. Am J Med Genet 127A:224\u2013229. https:\/\/doi.org\/10.1002\/ajmg.a.20650","journal-title":"Am J Med Genet"},{"key":"4706_CR13","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1200\/JCO.2011.34.5843","volume":"30","author":"E Bouffet","year":"2012","unstructured":"Bouffet E, Jakacki R, Goldman S, Hargrave D, Hawkins C, Shroff M, Hukin J, Bartels U, Foreman N, Kellie S, Hilden J, Etzl M, Wilson B, Stephens D, Tabori U, Baruchel S (2012) Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol 30:1358\u20131363. https:\/\/doi.org\/10.1200\/JCO.2011.34.5843","journal-title":"J Clin Oncol"},{"key":"4706_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/0883073817739509","volume":"33","author":"CJ Campen","year":"2018","unstructured":"Campen CJ, Gutmann DH (2018) Optic pathway gliomas in neurofibromatosis type 1. J Child Neurol 33:73\u201381. https:\/\/doi.org\/10.1177\/0883073817739509","journal-title":"J Child Neurol"},{"key":"4706_CR15","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1167\/iovs.06-0429","volume":"48","author":"BCM Chang","year":"2007","unstructured":"Chang BCM, Mirabella G, Yagev R, Banh M, Mezer E, Parkin PC, Westall CA, Buncic JR (2007) Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials. Invest Ophthalmol Vis Sci 48:2895\u20132902. https:\/\/doi.org\/10.1167\/iovs.06-0429","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4706_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jaapos.2010.08.014","volume":"14","author":"L Chang","year":"2010","unstructured":"Chang L, El-Dairi MA, Frempong TA, Burner EL, Bhatti MT, Young TL, Leigh F (2010) Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas. J AAPOS 14:511\u2013517. https:\/\/doi.org\/10.1016\/j.jaapos.2010.08.014","journal-title":"J AAPOS"},{"key":"4706_CR17","doi-asserted-by":"publisher","unstructured":"Dalla Via P, Opocher E, Luisa Pinello M, Calderone M, Viscardi E, Clementi M, Antonio Battistella P, Maria Laverda A, Da Dalt L, Perilongo G (2007) Neuro-oncology visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Neuro-Oncology 9:430\u2013437. doi: https:\/\/doi.org\/10.1215\/15228517-2007-031","DOI":"10.1215\/15228517-2007-031"},{"key":"4706_CR18","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1097\/00006123-199606000-00010","volume":"38","author":"AV Deliganis","year":"1996","unstructured":"Deliganis AV, Geyer JR, Berger MS (1996) Prognostic significance of type 1 neurofibromatosis (von Recklinghausen disease) in childhood optic glioma. Neurosurgery 38:1114\u20131119. https:\/\/doi.org\/10.1097\/00006123-199606000-00010","journal-title":"Neurosurgery"},{"key":"4706_CR19","first-page":"496","volume":"38","author":"V Dobson","year":"1997","unstructured":"Dobson V, Quinn GE, Balder JD, Hardy RJ, Reynolds JD, Siatkowski RM, Trese MT, Tung B (1997) Agreement between grating acuity at age 1 year and Snellen acuity at age 5.5 years in the preterm child. Investig Ophthalmol Vis Sci 38:496\u2013503","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4706_CR20","first-page":"67","volume":"13","author":"D Doro","year":"1990","unstructured":"Doro D (1990) Optic neuropathies: diagnostic role of standardized echography. Metab Pediatr syst Opthalmol 13:67\u201371","journal-title":"Metab Pediatr syst Opthalmol"},{"key":"4706_CR21","doi-asserted-by":"publisher","unstructured":"Estrada M, Kelly JP, Wright J, Phillips JO, Weiss A (2019) Visual function, brain imaging, and physiological factors in children with asymmetric nystagmus due to chiasmal gliomas. doi: https:\/\/doi.org\/10.1016\/j.pediatrneurol.2019.03.021","DOI":"10.1016\/j.pediatrneurol.2019.03.021"},{"key":"4706_CR22","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1158\/1078-0432.CCR-17-0590","volume":"23","author":"DGR Evans","year":"2017","unstructured":"Evans DGR, Salvador H, Chang VY, Erez A, Voss SD, Druker H, Scott HS, Tabori U (2017) Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 2 and related disorders. Clin Cancer Res 23:e54\u2013e61. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0590","journal-title":"Clin Cancer Res"},{"key":"4706_CR23","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1136\/bjophthalmol-2017-311305","volume":"102","author":"K Falzon","year":"2018","unstructured":"Falzon K, Drimtzias E, Picton S, Simmons I (2018) Clinical science visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort Leeds Teaching Hos. Br J Ophthalmol 102:1367\u20131371. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311305","journal-title":"Br J Ophthalmol"},{"key":"4706_CR24","doi-asserted-by":"publisher","unstructured":"Fangusaro J, Onar-thomas A, Poussaint TY, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S, Pollack IF, Qaddoumi I, Jakacki RI, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Jones DTW, Pfister SM, Vezina G, Stern JS, Panigrahy A, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M (2019) Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Lancet Oncol 20:1011\u20131022. doi: https:\/\/doi.org\/10.1016\/S1470-2045(19)30277-3","DOI":"10.1016\/S1470-2045(19)30277-3"},{"key":"4706_CR25","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1007\/s00417-013-2394-4","volume":"251","author":"MA Fard","year":"2013","unstructured":"Fard MA, Fakhree S, Eshraghi B (2013) Correlation of optical coherence tomography parameters with clinical and radiological progression in patients with symptomatic optic pathway gliomas. Graefes Arch Clin Exp Ophthalmol 251:2429\u20132436. https:\/\/doi.org\/10.1007\/s00417-013-2394-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4706_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/jmg.2006.045906","volume":"44","author":"RE Ferner","year":"2007","unstructured":"Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis. J Med Genet 44:81\u201388. https:\/\/doi.org\/10.1136\/jmg.2006.045906","journal-title":"J Med Genet"},{"key":"4706_CR27","doi-asserted-by":"crossref","unstructured":"Fisher MJ, Avery RA, Allen JC, Ardern-Holmes SL, Bilaniuk LT, Ferner RE, Gutmann DH, Listernick R, Martin S, Ullrich NJ, Liu GT (2013) Functional outcome measures for NF1-associated optic pathway glioma clinical trials","DOI":"10.1212\/01.wnl.0000435745.95155.b8"},{"key":"4706_CR28","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/neuonc\/nos076","volume":"14","author":"MJ Fisher","year":"2012","unstructured":"Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT (2012) Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro-Oncology 14:790\u2013797. https:\/\/doi.org\/10.1093\/neuonc\/nos076","journal-title":"Neuro-Oncology"},{"key":"4706_CR29","doi-asserted-by":"publisher","unstructured":"Gayre GS, Scott IU, Feuer W, Saunders TG, Michael Siatkowski R (2001) Long-term visual outcome in patients with anterior visual pathway gliomas. J Neuro-Ophthalmology. https:\/\/doi.org\/10.1097\/00041327-200103000-00001","DOI":"10.1097\/00041327-200103000-00001"},{"key":"4706_CR30","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s004310000531","volume":"159","author":"J Grill","year":"2000","unstructured":"Grill J, Laithier \u00c2, Ronique Laithier V, Rodriguez D, Raquin M-A, Pierre-Kahn A, Kalifa C (2000) When do children with optic pathway tumours need treatment\u00a0? An oncological perspective in 106 patients treated in a single centre. Eur J Pediatr 159:692\u2013696. https:\/\/doi.org\/10.1007\/s004310000531","journal-title":"Eur J Pediatr"},{"key":"4706_CR31","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1167\/iovs.13-13119","volume":"55","author":"S Gu","year":"2014","unstructured":"Gu S, Glaug N, Cnaan A, Packer RJ, Avery RA (2014) Ganglion cell layer-inner plexiform layer thickness and vision loss in young children with optic pathway gliomas. Investig Ophthalmol Vis Sci 55:1402\u20131408. https:\/\/doi.org\/10.1167\/iovs.13-13119","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4706_CR32","doi-asserted-by":"publisher","unstructured":"Hawkins C, Walker E, Mohamed N (2011) BRAF-KIAA1549 Fusion predicts better clinical outcome in pediatric low-grade astrocytoma. 4790\u20134798. doi: https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0034","DOI":"10.1158\/1078-0432.CCR-11-0034"},{"key":"4706_CR33","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s00417-018-4007-8","volume":"256","author":"M Hepokur","year":"2018","unstructured":"Hepokur M, Sarici AM (2018) Investigation of retinal nerve fiber layer thickness and ganglion cell layer-inner plexiform layer thickness in patients with optic pathway gliomas. Graefes Arch Clin Exp Ophthalmol 256:1757\u20131765. https:\/\/doi.org\/10.1007\/s00417-018-4007-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4706_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1023\/a:1015719803719","volume":"105","author":"A Iannaccone","year":"2002","unstructured":"Iannaccone A, McCluney RA, Brewer VR, Spiegel PH, Taylor JS, Kerr NC, Pivnick EK (2002) Visual evoked potentials in children with neurofibromatosis type 1. Doc Ophthalmol 105:63\u201381. https:\/\/doi.org\/10.1023\/a:1015719803719","journal-title":"Doc Ophthalmol"},{"key":"4706_CR35","doi-asserted-by":"crossref","unstructured":"Jay WM (2016) Neuro-ophthalmology illustrated, 2nd edition by Val\u00e9rie Biousse and Nancy J. Newman. Taylor & Francis, New York","DOI":"10.1080\/01658107.2016.1214738"},{"key":"4706_CR36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/pbc.24726","volume":"61","author":"E Kalin-Hajdu","year":"2014","unstructured":"Kalin-Hajdu E, D\u00e9carie J-C, Marzouki M, Carret A-S, Ospina LH (2014) Visual acuity of children treated with chemotherapy for optic pathway gliomas. Pediatr Blood Cancer 61:223\u2013227. https:\/\/doi.org\/10.1002\/pbc.24726","journal-title":"Pediatr Blood Cancer"},{"key":"4706_CR37","doi-asserted-by":"crossref","unstructured":"Kaufman LM, Doroftei O (2006) Optic glioma warranting treatment in children. Eye. Nature Publishing Group, pp 1149\u20131164","DOI":"10.1038\/sj.eye.6702379"},{"key":"4706_CR38","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.ophtha.2011.12.035","volume":"119","author":"JP Kelly","year":"2012","unstructured":"Kelly JP, Leary S, Khanna P, Weiss AH (2012) Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas. Ophthalmology 119:1231\u20131237. https:\/\/doi.org\/10.1016\/j.ophtha.2011.12.035","journal-title":"Ophthalmology"},{"key":"4706_CR39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jaapos.2006.02.003","volume":"10","author":"JP Kelly","year":"2006","unstructured":"Kelly JP, Weiss AH (2006) Comparison of pattern visual-evoked potentials to perimetry in the detection of visual loss in children with optic pathway gliomas. J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus 10:298\u2013306. https:\/\/doi.org\/10.1016\/j.jaapos.2006.02.003","journal-title":"J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"4706_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ajmg.a.20211","volume":"122A","author":"A King","year":"2003","unstructured":"King A, Listernick R, Charrow J, Piersall L, Gutmann DH (2003) Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome. Am J Med Genet 122A:95\u201399. https:\/\/doi.org\/10.1002\/ajmg.a.20211","journal-title":"Am J Med Genet"},{"key":"4706_CR41","unstructured":"Kornreich L, Blaser S, Schwarz M, Shuper A, Vishne TH, Cohen IJ, Faingold R, Michovitz S, Koplewitz B, Horev G (2001) Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. Am J Neuroradiol"},{"key":"4706_CR42","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0161-6420(84)34217-8","volume":"91","author":"RA Lewis","year":"1984","unstructured":"Lewis RA, Gerson LP, Axelson KA, Riccardi VM, Whitford RP (1984) von Recklinghausen neurofibromatosis: II. Incidence of optic gliomata. Ophthalmology 91:929\u2013935. https:\/\/doi.org\/10.1016\/S0161-6420(84)34217-8","journal-title":"Ophthalmology"},{"key":"4706_CR43","first-page":"60614","volume":"105","author":"R Listernick","year":"2001","unstructured":"Listernick R, Charrow JGD (2001) Letter to the editor comments on neurofibromatosis 1 and optic pathway tumors. Am J Med Genet 105:60614","journal-title":"Am J Med Genet"},{"key":"4706_CR44","doi-asserted-by":"publisher","unstructured":"Listernick R, Charrow J, Greenwald M, Mets M (1994) Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr. https:\/\/doi.org\/10.1016\/S0022-3476(94)70122-9","DOI":"10.1016\/S0022-3476(94)70122-9"},{"key":"4706_CR45","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S0022-3476(89)80137-4","volume":"114","author":"R Listernick","year":"1989","unstructured":"Listernick R, Charrow J, Greenwald MJ, Esterly NB (1989) Optic gliomas in children with neurofibromatosis type 1. J Pediatr 114:788\u2013792. https:\/\/doi.org\/10.1016\/S0022-3476(89)80137-4","journal-title":"J Pediatr"},{"key":"4706_CR46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ana.21107","volume":"61","author":"R Listernick","year":"2007","unstructured":"Listernick R, Ferner RE, Liu GT, Gutmann DH (2007) Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61:189\u2013198. https:\/\/doi.org\/10.1002\/ana.21107","journal-title":"Ann Neurol"},{"key":"4706_CR47","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1212\/01.WNL.0000144341.16830.01","volume":"63","author":"R Listernick","year":"2004","unstructured":"Listernick R, Ferner RE, Piersall L, Sharif S, Gutmann DH, Charrow J (2004) Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology 63:1944\u20131946. https:\/\/doi.org\/10.1212\/01.WNL.0000144341.16830.01","journal-title":"Neurology"},{"key":"4706_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/ana.410410204","volume":"41","author":"R Listernick","year":"1997","unstructured":"Listernick R, Louis DN, Packer RJ, Gutmann DH (1997) Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force. Ann Neurol 41:143\u2013149. https:\/\/doi.org\/10.1002\/ana.410410204","journal-title":"Ann Neurol"},{"key":"4706_CR49","doi-asserted-by":"publisher","unstructured":"Liu GT, Brodsky MC, Phillips PC, Belasco J, Janss A, Golden JC, Bilaniuk LL, Burson GT, Duhaime AC, Sutton LN (2004) Optic radiation involvement in optic pathway gliomas in neurofibromatosis. Am J Ophthalmol. https:\/\/doi.org\/10.1016\/j.ajo.2003.09.055","DOI":"10.1016\/j.ajo.2003.09.055"},{"key":"4706_CR50","volume-title":"Walsh and Hoyt\u2019s clinical neuro-ophthalmology","author":"NR Miller","year":"2004","unstructured":"Miller NR, Newman NJ, Biousse V, Kerrison JB (2004) Walsh and Hoyt\u2019s clinical neuro-ophthalmology, 6th edn. Lippincott Williams & Wilkins (LWW), Philadelphia","edition":"6"},{"key":"4706_CR51","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/pbc.22198","volume":"53","author":"G Nicolin","year":"2009","unstructured":"Nicolin G, Parkin P, Mabbott D, Hargrave D, Bartels U, Tabori U, Rutka J, Buncic JR, Bouffet E (2009) Natural history and outcome of optic pathway gliomas in children. Pediatr Blood Cancer 53:1231\u20131237. https:\/\/doi.org\/10.1002\/pbc.22198","journal-title":"Pediatr Blood Cancer"},{"key":"4706_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-016-9553-y","volume":"133","author":"JV Odom","year":"2016","unstructured":"Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Mizota A, Tormene AP (2016) ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol 133:1\u20139. https:\/\/doi.org\/10.1007\/s10633-016-9553-y","journal-title":"Doc Ophthalmol"},{"key":"4706_CR53","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1200\/JCO.1993.11.5.850","volume":"11","author":"RJ Packer","year":"1993","unstructured":"Packer RJ, Lange B, Ater J, Nicholson HS, Allen J, Walker R, Prados M, Jakacki R, Reaman G, Needles MN (1993) Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11:850\u2013856. https:\/\/doi.org\/10.1200\/JCO.1993.11.5.850","journal-title":"J Clin Oncol"},{"key":"4706_CR54","doi-asserted-by":"publisher","first-page":"8112","DOI":"10.1167\/iovs.13-13093","volume":"54","author":"R Parrozzani","year":"2013","unstructured":"Parrozzani R, Clementi M, Kotsafti O, Miglionico G, Trevisson E, Orlando G, Pilotto E, Midena E (2013) Optical coherence tomography in the diagnosis of optic pathway gliomas. Invest Ophthalmol Vis Sci 54:8112\u20138118. https:\/\/doi.org\/10.1167\/iovs.13-13093","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4706_CR55","doi-asserted-by":"publisher","first-page":"e1004","DOI":"10.1111\/aos.13803","volume":"96","author":"R Parrozzani","year":"2018","unstructured":"Parrozzani R, Miglionico G, Leonardi F, Pulze S, Trevisson E, Clementi M, Opocher E, Licata V, Viscardi E, Pilotto E, Frizziero L, Midena E (2018) Correlation of peripapillary retinal nerve fibre layer thickness with visual acuity in paediatric patients affected by optic pathway glioma. Acta Ophthalmol 96:e1004\u2013e1009. https:\/\/doi.org\/10.1111\/aos.13803","journal-title":"Acta Ophthalmol"},{"key":"4706_CR56","doi-asserted-by":"publisher","unstructured":"Patel DE, Cumberland PM, Walters BC, Russell I (2015) Study of optimal perimetric testing in children (OPTIC ): feasibility, reliability and repeatability of perimetry in children. 1\u201312. doi: https:\/\/doi.org\/10.1371\/journal.pone.0130895","DOI":"10.1371\/journal.pone.0130895"},{"key":"4706_CR57","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1111\/aos.14219","volume":"98","author":"OA Pf\u00e4ffli","year":"2020","unstructured":"Pf\u00e4ffli OA, Tam\u00e1si B, Hanson JVM, Gerth-Kahlert C (2020) Colour vision testing in young children with reduced visual acuity. Acta Ophthalmol 98:e113\u2013e120. https:\/\/doi.org\/10.1111\/aos.14219","journal-title":"Acta Ophthalmol"},{"key":"4706_CR58","doi-asserted-by":"publisher","unstructured":"Prada CE, Robert R, Hummel TR, Lovell AM, Hopkin RJ, Saal HM, Schorry EK (2015) The use of magnetic resonance imaging screening for optic pathway gliomas in children with neurofibromatosis Type 1. J Pediatr. https:\/\/doi.org\/10.1016\/j.jpeds.2015.07.001","DOI":"10.1016\/j.jpeds.2015.07.001"},{"key":"4706_CR59","doi-asserted-by":"publisher","unstructured":"Robert-Boire Bsc V, Rosca L, Samson Y, Ospina LH, Perreault S (2017) Clinical presentation and outcome of patients with optic pathway glioma. doi: https:\/\/doi.org\/10.1016\/j.pediatrneurol.2017.06.019","DOI":"10.1016\/j.pediatrneurol.2017.06.019"},{"key":"4706_CR60","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/pbc","volume":"57","author":"B Shofty","year":"2011","unstructured":"Shofty B, Ben-Sira L, Freedman S, Yalon M, Dvir R, Weintraub M, Toledano H, Constantini S, Kesler A (2011) Visual outcome following chemotherapy for progressive optic pathway gliomas. Pediatr Blood Cancer 57:481\u2013485. https:\/\/doi.org\/10.1002\/pbc","journal-title":"Pediatr Blood Cancer"},{"key":"4706_CR61","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1227\/NEU.0000000000000257","volume":"74","author":"B Shofty","year":"2014","unstructured":"Shofty B, Constantini S, Bokstein F, Ram Z, Ben-Sira L, Freedman S, Vainer G, Kesler A (2014) Optic pathway gliomas in adults. Neurosurgery 74:273\u2013279. https:\/\/doi.org\/10.1227\/NEU.0000000000000257","journal-title":"Neurosurgery"},{"key":"4706_CR62","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/pbc.25480","volume":"62","author":"B Shofty","year":"2015","unstructured":"Shofty B, Mauda-Havakuk M, Weizman L, Constantini S, Ben-Bashat D, Dvir R, Pratt LT, Joskowicz L, Kesler A, Yalon M, Ravid L, Ben-Sira L (2015) The effect of chemotherapy on optic pathway gliomas and their sub-components: a volumetric MR analysis study. Pediatr Blood Cancer 62:1353\u20131359. https:\/\/doi.org\/10.1002\/pbc.25480","journal-title":"Pediatr Blood Cancer"},{"key":"4706_CR63","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00381-011-1436-7","volume":"27","author":"B Shofty","year":"2011","unstructured":"Shofty B, Weizman L, Joskowicz L, Constantini S, Kesler A, Ben-Bashat D, Yalon M, Dvir R, Freedman S, Roth J, Ben-Sira L (2011) MRI internal segmentation of optic pathway gliomas: clinical implementation of a novel algorithm. Childs Nerv Syst 27:1265\u20131272","journal-title":"Childs Nerv Syst"},{"key":"4706_CR64","doi-asserted-by":"publisher","first-page":"266","DOI":"10.31729\/jnma.2743","volume":"53","author":"RK Shrestha","year":"2015","unstructured":"Shrestha RK, Shrestha GS (2015) Assessment of color vision among school children: a comparative study between the ishihara test and the farnsworth D-15 test. J Nepal Med Assoc 53:266\u2013269. https:\/\/doi.org\/10.31729\/jnma.2743","journal-title":"J Nepal Med Assoc"},{"key":"4706_CR65","doi-asserted-by":"publisher","unstructured":"Shute RH, Westall CA (2000) Use of the Mollon-Reffin minimalist color vision test with young children. 366\u2013372. doi: https:\/\/doi.org\/10.1067\/mpa.2000.110335","DOI":"10.1067\/mpa.2000.110335"},{"key":"4706_CR66","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jaapos.2006.06.002","volume":"10","author":"RM Siatkowski","year":"2006","unstructured":"Siatkowski RM (2006) VEP testing and visual pathway gliomas: not quite ready for prime time. J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus 10:293\u2013295","journal-title":"J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"4706_CR67","doi-asserted-by":"crossref","unstructured":"Sigorini M, Zuccoli G, Ferrozzi F, Bacchini E, Street ME, Piazza P, Rossi M, Virdis R (2000) Magnetic resonance findings and ophthalmologic abnormalities are correlated in patients with neurofibromatosis type 1 (NF1). 272:269\u2013272","DOI":"10.1002\/1096-8628(20000814)93:4<269::AID-AJMG3>3.0.CO;2-Y"},{"key":"4706_CR68","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/adc.87.1.65","volume":"87","author":"S Singhal","year":"2002","unstructured":"Singhal S, Birch JM, Kerr B, Lashford L, Evans DGR (2002) Neurofibromatosis type 1 and sporadic optic gliomas. Arch Dis Child 87:65\u201370. https:\/\/doi.org\/10.1136\/adc.87.1.65","journal-title":"Arch Dis Child"},{"key":"4706_CR69","doi-asserted-by":"publisher","unstructured":"Stiebel-kalish H, Lusky M, Yassur Y, Kalish Y, Shuper A, Erlich R, Lubman S, Snir M (2004) Swedish interactive thresholding algorithm fast for following visual fields in prepubertal idiopathic intracranial. 1673\u20131675. doi: https:\/\/doi.org\/10.1016\/j.ophtha.2004.03.031","DOI":"10.1016\/j.ophtha.2004.03.031"},{"key":"4706_CR70","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/01.icu.0000193070.32369.37","volume":"17","author":"CL Sylvester","year":"2006","unstructured":"Sylvester CL, Drohan LA, Sergott RC (2006) Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1. Curr Opin Ophthalmol 17:7\u201311. https:\/\/doi.org\/10.1097\/01.icu.0000193070.32369.37","journal-title":"Curr Opin Ophthalmol"},{"key":"4706_CR71","doi-asserted-by":"publisher","unstructured":"Thiagalingam S, Flaherty M, Billson F, North K (2004) Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Ophthalmology. https:\/\/doi.org\/10.1016\/j.ophtha.2003.06.008","DOI":"10.1016\/j.ophtha.2003.06.008"},{"key":"4706_CR72","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11060-017-2517-6","volume":"134","author":"E Trevisson","year":"2017","unstructured":"Trevisson E, Cassina M, Opocher E, Vicenzi V, Lucchetta M, Parrozzani R, Miglionico G, Mardari R, Viscardi E, Midena E, Clementi M (2017) Natural history of optic pathway gliomas in a cohort of unselected patients affected by neurofibromatosis 1. J Neuro-Oncol 134:279\u2013287. https:\/\/doi.org\/10.1007\/s11060-017-2517-6","journal-title":"J Neuro-Oncol"},{"key":"4706_CR73","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/s1388-2457(03)00282-7","volume":"115","author":"MTS Trisciuzzi","year":"2004","unstructured":"Trisciuzzi MTS, Riccardi R, Piccardi M, Iarossi G, Buzzonetti L, Dickmann A, Colosimo CJ, Ruggiero A, Di Rocco C, Falsini B (2004) A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas. Clin Neurophysiol Off J Int Fed Clin Neurophysiol 115:217\u2013226. https:\/\/doi.org\/10.1016\/s1388-2457(03)00282-7","journal-title":"Clin Neurophysiol Off J Int Fed Clin Neurophysiol"},{"key":"4706_CR74","doi-asserted-by":"publisher","unstructured":"Tsang DS, Murphy ES, Merchant TE (2017) Radiation therapy for optic pathway and hypothalamic low-grade gliomas in children. Int J Radiat Oncol Biol Phys 99:642\u2013651. doi: https:\/\/doi.org\/10.1016\/j.ijrobp.2017.07.023","DOI":"10.1016\/j.ijrobp.2017.07.023"},{"key":"4706_CR75","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.media.2011.07.001","volume":"16","author":"L Weizman","year":"2012","unstructured":"Weizman L, Ben Sira L, Joskowicz L, Constantini S, Precel R, Shofty B, Ben Bashat D (2012) Automatic segmentation, internal classification, and follow-up of optic pathway gliomas in MRI. Med Image Anal 16:177\u2013188. https:\/\/doi.org\/10.1016\/j.media.2011.07.001","journal-title":"Med Image Anal"},{"key":"4706_CR76","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jaapos.2006.02.004","volume":"10","author":"DH Wolsey","year":"2006","unstructured":"Wolsey DH, Larson SA, Creel D, Hoffman R (2006) Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus 10:307\u2013311. https:\/\/doi.org\/10.1016\/j.jaapos.2006.02.004","journal-title":"J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"4706_CR77","doi-asserted-by":"publisher","unstructured":"Yanni SE, Wang J, Cheng CS, Locke KI, Wen Y, Birch DG, Birch EE (2013) Normative reference ranges for the retinal nerve fiber layer, macula, and retinal layer thicknesses in children. Am J Ophthalmol. https:\/\/doi.org\/10.1016\/j.ajo.2012.08.010","DOI":"10.1016\/j.ajo.2012.08.010"},{"key":"4706_CR78","doi-asserted-by":"publisher","unstructured":"Zahavi A, Toledano H, Cohen R, Sella S, Luckman J, Michowiz S, Goldenberg-Cohen N (2018) Use of optical coherence tomography to detect retinal nerve fiber loss in children with optic pathway glioma. Front Neurol 9. https:\/\/doi.org\/10.3389\/fneur.2018.01102","DOI":"10.3389\/fneur.2018.01102"},{"key":"4706_CR79","doi-asserted-by":"publisher","unstructured":"Zeid JL, Charrow J, Sandu M, Goldman S, Listernick R (2006) Orbital optic nerve gliomas in children with neurofibromatosis type 1. J AAPOS. https:\/\/doi.org\/10.1016\/j.jaapos.2006.03.014","DOI":"10.1016\/j.jaapos.2006.03.014"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-020-04706-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-020-04706-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-020-04706-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T23:29:48Z","timestamp":1628033388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-020-04706-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,4]]},"references-count":79,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4706"],"URL":"https:\/\/doi.org\/10.1007\/s00381-020-04706-3","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,4]]},"assertion":[{"value":"1 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}